Meet our Ambassadors

Olorunsola Niyi Bankole is a veterinarian and virologist working as a Field Diagnostic Manager at Zoetis ALPHA initiative in Nigeria. Olorunsola is involved in training and education of all stakeholders in livestock industry, development and strengthening of livestock diagnostic networks as well as in epidemiological studies of livestock diseases. Currently, he encourages farmers to embrace good bio security measures, proper management and the use of laboratory to determine the proper vaccination timing and correct antibiotics when need be. Olorunsola also encourage the use of laboratory diagnosis. This helps in adjusting some management of livestock instead of abuse of antibiotics. When needed, appropriate options and dosages are also given based on laboratory test outcomes. In the nearest future, he will be considering the aspects of quality control especially in poultry feed and feeding raw materials. As mycotoxins can make flocks susceptible to all sorts of conditions hence increase the usage of antibiotics unnecessarily.

Gilles Courtemanche is the Antimicrobials Program Head at Bioaster in France. Gilles is involved in editing public-private partnerships to curve AMR and to combat (re)-emerging infectious diseases. Bioaster, the technology research institute, dedicated to infectious diseases and microbiology, is part of the French government’s response to the AMR challenge. The mission of the Institute is to develop innovative technologies that allow our industrial partners to discover and develop faster, better therapeutic solutions, at a lower cost. For this, Bioaster operates in three complementary domains of application, Drug, Vaccine and Diagnostics but also in more alternative approaches such as microbiota, phage-therapy, host-oriented treatments, botanical drugs or traditional medicines. This multidisciplinary approach allows Bioaster to identify synergies, complementarities and opportunities to more effectively address unmet medical needs by means of truly innovative solutions developed during collaborative projects sharing scientific, technical and financial risks.


Zoumana Isaac Traore is Antimicrobial Resistance Officer at the World Health Organization (WHO) in Mauretania. Zoumane assists the Mauritanian Government in developing and implementing a National Action Plan to combat AMR. In particular he is involved in raising awarness among health practitioners and the general public while advocating for policy change/development for the containment of AMR.

Abraham Allotey is a agriculturist, wood technologist and apiaculturist in beekeeping technology development, working for Allotey Honey Bee Farms in Ghana. Abraham focuses on the development of technology for harvesting propolis to manage AMR. He is also involved in the Forestry Commission Ghana. Abraham is involved in promoting propolis harvesting, processing and utilization of honey for AMR management.

Uwe Albrecht is by origin a medical doctor and currently is the CEO of Mediconomics in Germany. Following education in the Faculty of Medicine of Marburg University and four year experience in clinical and academic medicine Uwe worked for Behringwerke and later for Glaxo Group Research (both UK an Germany) before founding Mediconomics. Uwe has published widely in the area of pharmaceutical medicine and related subjects. He is Chartered Scientist, Member of the WMA, Royal College of Physicians, Faculty of Pharmaceutical Medicine and Fellow of the Institute for Biomedical Science. Uwe is a leading driver in clinical research of phytomedicinal products with antibacterial efficacy and the development of associated medicinal products on peptide basis. 

Ibrahima Lo is the National One Health/AMR Expert at the Emergency Center for Transboundary Animal Diseases of Food and Agriculture Organization (FAO-ECTAD) in Senegal. Inbrahima contributes to the preparation of National strategies and One Health programme for the management of emerging and re-emerging, zoonotic or non-zoonotic diseases with high impact in Global Health security and food safety. He also establishes contacts in order to improve collaboration between One Health actors at national and regional level, identify and share good practices and tools to support timely decision-making, contribute to strengthening the institutional leadership and technical capacities of the One Health Platform and to support the National One Health platform to better identify and understand the global, regional and national issues of the One health approach. 

Adeola Ayeni is a Clinical Pharmacist in the Department of Pharmaceutical Services University College Hospital (UCH), Ibadan, Oyo State, Nigeria. He is a member of the Antimicrobial Stewardship Committee of this Institution. Adeola is very passionate about infection control and antimicrobial resistance. He is committed to eliminating antimicrobial resistance because of its global impact. Ayeni’s job description includes providing Pharmaceutical Care to ambulatory patients and in-patients (ICU, HDU inclusive). As a medicine use expert, he is charged with the responsibility of providing information on medicine use and monitoring of patients` therapeutic outcome. Furthermore, he is a strong advocate of antimicrobial resistance in every professional environment he finds himself. Adeola celebrated the 2019 World Antibiotics week in collaboration with other members of the healthcare team in the institution where he works by providing educational support to the members of the public and the hospital community. He desires to further combat the spread of AMR.

Luisa Fernanda Toro-Alzate is a medical doctor with knowledge in basic and clinical sciences, research training and emergency clinic experience. Luisa is of Colombian origin and currently coursing her master studies in Public Health at the Royal Tropical Institute KIT in The Netherlands. Her intended contribution to curbing Antimicrobial resistance will be the description and analysis of the public policies and their implementation in low and middle-income countries. Places where the indiscriminate use of antibiotics have increased and contributed to the spread of AMR. Also, she wants to add improving these policies to diminish the AMR burden.

Muhammad Farooq Tahir is a Veterinary Microbiologist and graduate of Field Epidemiology and Laboratory Training Program (FELTP), Pakistan. The work of Muhammed has been focused on zoonosis including assessment of occupational health hazards for at risk communities against zoonotic diseases and use of mobile-based applications of real time disease surveillance. Muhammed is a Technical Advisor at Health Security Partners (HSP), USA. He is working with Fleming Fund Country Grant on AMR for Pakistan. His core responsibilities include assessment of laboratory capacity on AMR, development of capacity strengthening plans in consultation with in-country stakeholders and to develop and implement the AMR surveillance plan. Before that Muhammed was the Technical Advisor on One Health for Pakistan at Health Security Partners (HSP), USA.  As such he coordinated between human and animal health sectors at federal and provincial level for one-health activities, development of control and / or elimination programs for priority zoonotic diseases at national level. He also assisted in the development of key policy documents e.g. National One Health Strategic Framework.

David Akanbi is the founder of Caresite Pharmacy and Healthmart in Jericho, Nigeria. The pharmacy commenced Operations on September 1, 2016. David gets engaged with patient counselling with specialized pharmaceutical care services such as extemporaneous preparations. As the CEO and Most Senior Responsible pharmacist, he trains other pharmacists on adherence to the tenets of Antimicrobial Stewardship, and implements up-to-date community pharmacy practices. The site serves as an annex pharmacy to the largest teaching hospital in West Africa, called University Teaching Hospital, Ibadan (with more than 1,000 beds), where they source and stock rare and orphan medications, especially special antibiotics that may not be available at the hospital due to one reason or the other. Due to the fact that the Pharmacy has some broad spectrum antibiotics and ICU medications, David participated in 2018 and 2019 Antibiotics Awareness Week programs at the Teaching Hospital. They hope to go into a well established public-private partnership with the Laboratory Department, Clinical/Medical Microbiology, ICU and Pharmacy Departments of the teaching hospital (UCH) to provide infrastructural support, educational programs to the residents, PPE, and more affordable broad spectrum antibiotics respectively in order to lessen the burden of Antimicrobial Resistance in Nigeria.

Naomi Bull is a veterinary researcher working across inter-disciplinary areas related to global health. She works at the London School of Hygiene and Tropical Medicine in the UK. Naomi has a multi-disciplinary background in veterinary sciences, infectious disease immunology, vaccine development and public health and her research covers both the social and natural sciences. She is currently working as a Research Fellow, where her research interests in AMR take a One Health perspective, focused on the intersection between human and animal health and the environment. Naomi has worked in Kenya and India studying AMR in subsistence farming communities and has also been involved in creative public engagement activities around AMR with schoolchildren in India, Kenya and the UK. She is particularly interested in raising public awareness of AMR and promoting positive antimicrobial stewardship at the community level through her ongoing work.

Adeola Bamisaiye is currently a pharmacist intern at Obafemi Awolowo University Teaching Hospital, Ile-ife, Nigeria. She is passionate about Global health, with specific interest in antimicrobial resistance. She was a member of the only Nigerian team, selected as winners for the Innovate4AMR competition in 2018, hosted by the World Health Organization (WHO), ReAct-Action on Antibiotics resistance, International Federation of Medical Students Association (IFMSA), Johns Hopkins IDEA initiative and South centre.  Her team also championed a #100daysAwarenessOnAMR on social media. She is a trained science communicator who seeks to utilise her knowledge and skills in raising awareness about antimicrobial resistance. During the World Antibiotics Awareness Week (WAAW 2019), she spearheaded a team that raised awareness on AMR at secondary schools. She has also worked as a student researcher to generate AMR surveillance data from isolates obtained from Nigeria’s National Reference Laboratory.

Joseph Fadare is a Consultant Physician/Clinical Pharmacologist and Associate Professor working at the Ekiti State University Teaching Hospital/ Ekiti State University College of Medicine, Ado-Ekiti, Nigeria. Joseph teaches Clinical Pharmacology and Therapeutics to undergraduate medical students. He take courses on Antimicrobial Chemotherapy and Rational Use of Medicines. He also works as a consultant physician managing patients with infectious and non-communicable diseases. He also trains postgraduate resident doctors on rational prescribing of medicines including antimicrobials. Joseph has been conducting research on the availability and functionality of Drugs and Therapeutic Committees and Antimicrobial Stewardship Programs in Nigerian hospitals. Presently he is working on commencing an antimicrobial point prevalent study study across several sites in Nigeria.

Rhoda Ilenwabor is a Pharmacist with a passion for pharmacotherapeutics and drug design. She presently works at CHAN Medi-Pharm Jos, Nigeria as the Superintendent Pharmacist and a Monitoring Evaluation, Research and Learning officer. Her work involves monitoring and evaluating company activities and projects such as the procurement, sales and marketing of pharmaceuticals, supply chain of health products. Rhoda also works in the minilab to ensure that drug products dispatched to consumers are of quality standard. She also works with the research team. About Antimicrobial Resistance, she has done a poster presentation on Establishing the Weakest Link in the Fight against Antimicrobial Resistance. This was presented at the July 2019 ReAct conference on Antimicrobial Resistance in Nairobi, Kenya. In the near future Rhoda wants to work with environmentalists and farmers to pursue an end to the AMR scourge.

María Elena Báez Flores works at the Universidad Autónoma de Sinaloa in Mexico. Currently she is the Coordinator of the Master Degree and the Doctorate Program from the Facultad de Ciencias Químico Biológicas. Her research lines are Molecular Microbiology and Genomics of Antimicrobial Resistance. She teaches subjects of the Microbiology area (General Microbiology, Bacteriology, Micology, and Virology) to  pregrade students. At postgraduate level, she teaches Molecular Microbiology and Introduction to Bioinformatics. Maria has been conducting research on antimicrobial resistance determinants, mainly in E. coli and Staphylococcus spp. Also, her research group is looking for alternatives to antibiotics use. They investigate the effect of local and regional plant extracts on resistance and multiresistance bacterial strains obtained from patients or environmental studies performed in the lab.

Maduekwe Nkechi Perpetua is a resident doctor in the department of clinical microbiology at Nnamdi Azikiwe University Teaching Hospital Nnewi in  Nigeria. Her duties include seeing patients, attending to consults, running microbiology tests like urine m/c/s, blood culture etc. Maduekwe is a member of the infection prevention and control unit in her hospital. She has just completed an online course on the role of diagnostics in combatting antimicrobial resistance at the London school of tropical medicine and hygiene. In her role as an ambassador she will sensitize via social media about antimicrobial resistance. According Maduekwe the truth is that in Nigeria, the average citizen has no idea what AMR is. Maduekwe has been speaking out on her WhatsApp already. Even though she is a a doctor, it was after she completed that online course that I came to fully appreciate AMR and what it means to the future generation

Humphrey Aberi works as a county laboratory coordinator in remote Kenya  in a county known as Kakamega. He is in charge of 155 facilities where he coordinates HIV and TB services. Humphrey supports service providers to develop and implement programs to evaluate the quality and effectiveness of services and to implement improvements. In addition he develops protocols for ensuring compliance with practice guidelines and laboratory regulations. Humphrey also coordinates national and regional technical assistance including laboratory training, laboratory accreditation, laboratory audits and assessments. He implements new diagnostic techniques and is involved in training, coaching and mentor-ship of staffs on laboratory diagnostic methods.

Mashkoor Mohsin Gilani is working as Assistant Professor at Institute of Microbiology, University of Agriculture, Faisalabad, Pakistan. He leads a very vibrant research group on antimicrobial resistance (AMR).The focus of his research is the molecular epidemiology of multidrug resistant Gram negative bacteria at human-animal interface. He is currently addressing the issue of AMR and antimicrobial use, as this is a question of high importance since Pakistan has drafted its National Action Plan on AMR.  Mashkoor is investigating how evolution and spread of plasmid-mediated extended spectrum ß-lactamases (ESBLs), carbapenemase and mobile colistin resistance (mcr-1) in bacteria occurs in response to the extensive antimicrobial use (AMU) in human and livestock. He has reported the first article on AMU in food animals in Pakistan in Global Health Action. Mashkoor has been selected for FAO/WHO Panel of Expert on Foodborne Antimicrobial Resistance (2018-2022). In addition, he is member of the Surveillance and Epidemiology of Drug-resistant Infections Consortium (SEDRIC), Wellcome Trust, UK

Eva Garmendia is a Project Coordinator at the
Uppsala Antibiotic Center, Uppsala University in Sweden.

Prathamesh Sawant is a Clinical Pharmacist Practitioner and Co-Founder of AVEKSHA: Home Based Primary and Palliative Care; PCMH at the Restore Health Clinic in Bangalore, Karnataka, India. AVEKSHA was started as a Physician-Pharmacist Co-led model to deliver optimal medical needs to patients at their homes. AVEKSHA takes care of most of the patients with infectious causes at their home along with catering to other symptoms and manages complex infections. Prathamesh has done his dissertation on “Improving Rational Use of antimicrobials at a tertiary care hospital” to help build and update the antibiogram at the hospital and understand the usage and disease burden in the institution of practice. He is also working with his team (PCMH-MSCH) to collaboratively build an AMR protocol using the urban data from his dissertation and rural data from one of his colleagues dissertation to design a new device that will help catch infection at the early part and start the patient with best treatment plan available.

Rohini Wadanamby is the Head of the clinical microbiology diagnostics at the Lanka hospital (LHC) and Lanka Hospital diagnostics (LHD) Department of microbiology in Sri Lanka. For LHD she treats infections and infectious disease patients who were referred by other consultants or directly admitted under her. Rohini participates in a multitude of national programs related to AMR combatting through college of microbiologists, post graduate institute of medicine and Ministry of Health of Sri Lanka. She is involved in diagnostics (their lab is accredited with College of American Pathologists) and provides annual AMR reports based on susceptibility and resistance patterns to all permanent and visiting consultants. She carried out antibiotic stewardship program at the National Institute of infectious Diseases up to 2017. Also she is involved in teach post graduate students on AMR combatting programs and practices and writing to the papers and magazines (5 of them currently) on what public should know to prevent AMR, did lectures and programs with college of microbiologists, was involved in microbiomes associated programs and did several lectures on human, animal and environmental microbiome in Sri Lanka Medical Association forums. Also she is a mentor and supervisor for post graduate and under graduate students who do some work on AMR combating.

Tracy Nevitt is a Senior Scientist at Neem Biotech in the UK. Tracy has worked in the fields of infectious and rare diseases since she completed her PhD in Biochemistry. During her post-doc at Duke University, North Carolina, USA, she specialised in fungal and bacterial pathogenesis. She was a Duke Scholar in Infectious Diseases and trained at the Woods Hole Marine Biology Labs in Molecular Mycology. During this time, Tracy also led a discovery project on Menkes disease, an ultra-rare disease of systemic copper deficiency in children. Menkes disease became her lab’s main research focus as Assistant Professor at the University of Missouri, Columbia. Upon her transition into industry in 2013, Tracy has developed and led several translational projects infectious, probiotics and rare diseases, for biotech companies in the USA and Wales. Tracy currently leads the EB project at Neem Biotech and is a senior scientist working towards curbing AMR in Neem Biotech’s discovery and development pipelines for novel antibiotics and antimicrobials. Tracy is passionate about seeking scientific knowledge from the literature and in sharing all relevant information via social media to colleagues and AMR groups of interest.

Cristina Flemming is a Brazilian graphic designer that works with marketing in animal nutrition for more than ten years in Brazil and now in Germany. Cristina is a digital media specialist at EW Nutrition, a company that is a feed manufacturer. The products are directed for animals consumption as alternatives to antibiotics as growth promoters, which is also part of the  Mission and Vision of the company. It is part of her work to raise awareness on AMR. This is a threat of great importance. When she is talking about this with people that are not working with markets related to human and animal health, she finds it scary how big the lack of information is. She now shares a lot of information on AMR at LinkedIn and between the employees. She is also preparing the  Facebook page for the future to increase the awareness as well.

Yoshiaki Gu is chief of the Education and Information Division of the AMR Clinical Reference Center (AMRCRC), National Center for Global Health and Medicine Hospital in Tokyo, Japan AMRCRC was established in 2017 as a commissioned project of Ministry of Health, Labour and Welfare of Japan. As an MD and MPH Yoshi has been with the AMRCRC to enhance knowledge and awareness on AMR among medical personnel and general public in Japan. As a leader of awareness raising campaign, he manages promotion activities of AMRCRC including website, public events, media approach, seminars for medical personnel, media strategy and so on. Some activities are introduced in AMR CONTROL 2019-20.

Dhanuraj Shetty recently was at CARB-X as the Accelerator Lead in Boston, USA. He supported the CARB-X funded companies via the Accelerator network for their business and scientific needs  and was also instrumental in creating an operational framework for the Global Accelerator network. Before joining CARB-X, Raj was the Senior Director of Strategic Alliances and Partnership at The New York Stem Cell Foundation Research Institute. Raj also worked at the Juvenile Diabetes Research Foundation (JDRF) in a range of business development roles and was responsible for industry partnerships and alliances. He has over twelve years of industry experience, that included his time at KCI (now Allergan) and ten years at Johnson and Johnson where he lead research programs in the field of Regenerative Medicine. Raj has issued seven US Patents.  His original training and work experience was in engineering. As an Ambassador  Raj would like to get involved in educating the people of his home land India on AMR.

Andrew Kemp is a specialist in disinfection and decontamination and Head of Scientific Advisory Board of the British Institute of Cleaning Science in the UK.  Andrew is heavily involved in disinfectant resistance, and will continue to research and promote best practice in this. In addition Andrew is  a Principal Scientific Advisor to several Life Sciences companies as well as Infection Control Officer for Wimpole Aesthetic Clinic London and Zenith clinics Nottingham.

Steffanie Strathdee is an infectious disease epidemiologist, Associate Dean of Global Health Sciences and Harold Simon Professor of Medicine at the University of California San Diego in the USA. Steffanie codirects the Center for Innovative Phage Applications and Therapeutics.  She is married to Thomas L. Patterson, Professor of Psychiatry at UC San Diego. Steffanie was recently credited with saving her husband’s life from a deadly superbug infection using bacteriophages. The two co-authored a book on their story called The Perfect Predator: A Scientist’s Race to Save Her Husband from a Deadly Superbug. For her efforts to revitalize phage therapy in the West, she was named one of TIME magazine’s Most Influential People in Health Care in 2018.

Madhavi Annamanedi is a Department of Biotechnology-Research Associate at the National Institute of Animal Biotechnology in Hyderabad, India. During her doctoral studies she worked on antibiotic profiles and epidemiology of drug resistant ESKAPE pathogens from hospitals. Madhavi has been involved in developing and analyzing alternate antibacterial therapy to reduce antibiotic use in treating drug resistant bacterial infections. After joining NIAB, she worked on  epidemiology  of  bovine mastitis associated Staphylococcus aureus which is known for its drug resistance adaptations. At present she is working on antibiotic resistance during biofilm formation and  treatment options for effective use of existing antibiotics. Madhavi started her commitment to combat AMR personally by suggesting my family members, friend and students around not to use antibiotics until unless they are necessary. She would like to focus more in educating poor people in villages of her country how to use antibiotics properly (When to use, Duration and Dose etc).

Niv Bachnoff is the co-founder and CSO at Omnix Medical in Jerusalem, Israel. Omnix Medical is a biotechnology-company developing the next-generation antibiotics against drug resistant bacteria. The Omnix platform technology offers a pipeline of antimicrobial peptides at various stages of development. Its lead peptide, OMN6, has been granted QIDP Designation by the FDA and is being developed as treatment for life-threatening resistant infections. Omnix is dedicated to introduce an innovative family of antimicrobial agents, employing a new MoA to help in the fight against resistant bacteria. Once approved as a treatment, OMN6 has the potential to offer a much anticipated treatment to people around the world suffering from resistant bacteria.

Jeroen Dewulf graduated as a veterinarian and currently works as full professor in Veterinary Epidemiology at the faculty of Veterinary Medicine of Ghent University in Belgium. His main research interests are related to antimicrobial use and resistance in animals as well as the prevention of epidemic and endemic diseases with a focus on the application of disease prevention and biosecurity measures. Jeroen is the main developer of the biocheck.ugent biosecurity scoring system which is used worldwide as a tool for disease prevention in animal production. He is also responsible for the annual Belgian report on antimicrobial consumption in animals (BelVetSac) and chair of the JPI-AMR network on quantification of antimicrobial consumption in animals at herd level. In addition Jeroen is the founder and chair of the centre of expertise on antimicrobial use and resistance in animals (AMCRA) in Belgium. He has recently written the book “8 myths on antimicrobial resistance disproved, practical guide for reducing antibiotic use in animal husbandry”.

Sabiha Essack is Professor in Pharmaceutical Sciences and holds the South African Research Chair in Antibiotic Resistance & One Health at the College of Health Sciences, University of KwaZulu-Natal, Durban in South Africa. Sabiha is the Director of the Antimicrobial Research Unit (ARU) and General Secretary of the Academy of Science of South Africa (MASSAf). The ARU adopted the One Health approach, investigating antibiotic resistance in human, (food) animal and environmental health in keeping with the UN Political Declaration on Antimicrobial Resistance (AMR) and the associated Global Action Plan on AMR developed by the tripartite alliance of the World Health Organization (WHO), the Food and Agriculture Organization of the United Nations (FAO) and the World Organization for Animal Health (OiE). The ARU is committed to human capital development, creating a critical mass of PhD credentialed researchers and postdoctoral fellows in Africa with research knowledge and skills to generate evidence to optimally manage and contain antibiotic resistance in the One Health approach.


Yonghong Xiao is Professor and tutor for doctoral graduate, PI, Vice-director, State Key Laboratory of Diagnosis & Treatment of Infectious Diseases, 1st Affiliated Hospital, School of Medicine, Zhejiang University in China. Yonghong’s major interests include infectious diseases, basic and clinical researches in antimicrobial agents, bacterial resistant surveillance and mechanisms, clinical pharmacology and rational use of antibiotics. Yonghong is the founder & leader of MOH national antibacterial resistant investigation net from 2005 on, which have more than 1300 member hospitals. He is also a member of the National Committee for Drug Rational Use of China. He drafted the National Action Plan to Combat AMR of China. He conducted many international collaborative projects in AMR surveillance and control, which included Sweden, Great Britain, The Netherlands, EU and WPR, etc. Up to now, professor Xiao completed more than 30 national and international funded studies and over 50 clinical trials of new antimicrobial agents.

Amritanjali Kiran is working as a project associate at the Centre for Cellular and Molecular Platforms (C-CAMP) in Bangalore, India. Amritanjali is involved in the Antimicrobial Resistance Project. Her role includes outreach and spreading awareness about Antimicrobial Resistance. She is also involved in the outreach for CARB-X funding rounds. Amritanjali organizes workshops and delivers webinars and roadshows to spread awareness about Antimicrobial Resistance and funding opportunities available for AMR innovators and researchers. She is very much interested in spreading awareness about the AMR in Low and Middle Income countries by organizing workshops and webinars and by sharing new research articles/news/information etc among personal and professional networks. Also she would like to provide outreach about AMR opportunities available for students, innovators and researchers.

Satish Kumar is a Director Preclinical Research at PreviPharma Consulting GmbH, Mannheim, Germany. His major task  is ‘’know how’’ for the various research activities. Satish is involved from idea generation to development of preclinical data with strong team of scientists for unmet medical needs. He is also responsible for  the ‘’Medical Innovation Platform (MIP)‘’ to bridge the gap between Industry and Academia. PreviPharma works on various aspects of unmet medical needs and addressing AMR is one of core areas. Satish’ contribution towards curbing AMR is through research activities and by involving in various social aspects such delivering seminars on importance of use and misuse of antibiotics (under education program) and awareness programs.

Jovan Baryamujura is a Public health Specialist in Uganda. His major interests are on how the ecological dynamics can influence AMR in humans and animals. Jovan is currently working with a project called Drivers of Resistance in Uganda and Malawi (DRUM) with focal interest how human behaviour and antibacterial usage in the home, around animals and in the wider environment in urban and rural areas of Uganda and Malawi contributes to the spread of antibiotic resistance in bacteria. They plan to investigate which aspects of behaviour are most important in spreading antibiotic resistance by surveying human behaviour in relation to antibiotics, water, sanitation and hygiene and by investigating bacterial behaviour in response to these stimuli. The project aims to use cutting edge mathematical techniques to “model” which behaviours are most important and then use this information to work with policy experts in Uganda and Malawi to design potential interventions to prevent them from spreading further. Jovan also supports the One Health program that is ran annually by the London School of Tropical Medicine and Hygiene through its East African Diploma in Hygiene and Tropical medicine.

Mugerwa Ibrahimm is the AMR Program Coordinator for the National efforts to build and develop the AMR-One Health Program under the ministry of Health of Uganda. He is a fellow of the Fleming Fund AMR Capacity building program in the Human Health. Mugerwa and his team are working on piloting and developing a One Health AMR Surveillance program the first of its kind in the LMIC. Mugerwas coordination work is executed under the AMR- National Coordination Centre- NCC for human Health. Mugerwa is nominated to chair the GHSA-AMR Action Package Roundtable platform for 2019/2020 year round.

Joseph Zziwa is a Pharmacist at the Uganda Heart Institute (UHI), a parastatal leading provider of cardiovascular healthcare services in Uganda. UHI is charged with coordinating the prevention and treatment of cardiovascular disease.  He coordinates the supply of medicines from the National Medical Stores and private suppliers, participates in research and gives advice to patients regarding the proper use and storage of medicines. He’s a senior member on the Medicines and Therapeutic committee which ensures that all antimicrobial agents available are appropriate for patients with heart diseases. He is part of the team responsible for development of restricted antimicrobial-use procedures and therapeutic guidelines. In addition, he reviews prescribed antimicrobials for their appropriateness as well as disseminates AMR information to patients and health care providers. Joseph is actively involved in infection control and prevention programs which aim at limiting use of antimicrobials.

Mauricio Agudelo is the founder of Bialtec SAS in Colombia (SA). Mauricio is in charge of the strategic vision of the business and in directing the research on the reduction of antibiotics in animal nutrition of the research groups that work with Bialtec. Bialtec is designing a novel AI platform to predict changes in the animal gut microbiota and design the additives to remodel the microbiome in a healthy condition. Mauricio is a Chemical Engineer, University of Antioquia in Colombia and a serial entrepreneur. His main personal and professional goal is to reduce the use of antibiotics as a growth promoter in animal nutrition through natural feed additives such as essential oil, probiotics, phytogenics, prebiotics, and others microbiome modifiers to avoid side effects and keep supporting the greener production of animal protein (meat, milk, and eggs).

Beatrice King’ori is a laboratory epidemiologist working as a lab manager at Karatina Sub-County Hospital, Nyeri County, Kenya. Beatrice is a member of the Hospital management team, the County Antimicrobial Stewardship Interagency Committee (CASIC) and the Hospital IPC committee. She is secretary to the Hospital Quality Improvement Team (QIT) and a member of the hospital Medicines and Therapeutic Committee. Beatrice is assisting the County with outbreak investigations or any other assigned epidemiological work. She hopes to increase awareness about AMR in her circles and forums. Also she will pass updated information to my colleagues as regards AMR during IPC and QI trainings/sensitization forums and in social media too. Most importantly she wants to network with a team that is passionate and has expertise in AMS/R.

Srinivasan VK is the co-founder and director of ZeiniX Life Sciences in India. Srinivasan has been in the forefront of creating a blue-ocean in the field of molecular diagnostics for critical infections. Having dealt with antibiotic stewardship and the rising menace of AMR, he is very keen to contribute to the cause of creating awareness and to play a role in controlling reducing the global threat of AMR. He believes this man-made disaster can be managed thru evidence based diagnostics, educating clinicians and enabling the decision makers to institute antibiotics stewardship more meaningfully. Srinivasan is keen to associate with AMR Insights to further this challenging endeavor as an ambassador in India.

Lena Hannona is a clinical pharmacist at Cedars Sinai Medical Center in Los Angeles, Califonia, USA. Her job function is to optimize patient care by evaluating the appropriateness and effectiveness of the patient’s medications. Lena staffs across many specialties but is specifically passionate about infectious diseases and contributes to curbing AMR by participating in Antibiotic stewardship activities in hospitalized patients. Those include assisting in selecting appropriate empiric antibiotics, re-evaluating continued need for antibiotics after 48-72 hours, recommending to stop antibiotics if cultures are negative and infection is unlikely or when infection is resolved, screening for duplicate therapy and for drug-drug interactions, maximizing PK/PD parameters for dose optimization of antibiotics and recommending to switch therapy to the most appropriate antibiotics based on cultures and susceptibilities.

Dipanjan Chakraborty is the co-founder & director of ZeiniX Life Sciences in India. ZeiniX markets cutting edge biotech innovations with a socio-medical impact. Dipanjan is passionate about molecular diagnostics for infections. He has published several articles on Diagnostic Stewardship & AMR at ICU and clinical impact of molecular diagnostics in life threatening infections. Dipanjan aims to contribute to curbing AMR by writing on this global healthcare crisis (his own insights as well as compilation of recent developments), sharing new information/news/research articles etc in social media among his network, enhancing AMR awareness among his social & professional network and undertaking relevant activities in collaboration with ambassadors of AMR Insights.

Stephen Matenga is the Secretary General of the National Association of Freelance Journalists in Zimbabwe. The association has over 200 members from across the country freelancing for various media organisations. Stephen’s work is mainly administering the activities of the organisation. At the moment the organisation is establishing its own online media outlet which shall be launched in October. Stephen intends to curb Antimicrobial Resistance by educating and creating awareness through the following methods: by dedicating a section of the forthcoming publication to Antimicrobial Resistance education and coverage, setting up workshops to train journalists in understanding the topic so that through their coverage the public will be informed, and by engaging communities and policy makers on policy and interventions.

Arnold Ayebarr is a microbiologist with laboratory technologist background working for Partners In Health, Liberia. Arnold is currently working in the South-east of Liberia to set up a referral microbiology lab whose main aim is to start generating AMR surveillance data for the WHO GLASS reporting tool. He is stationed at JJ Dossen Hospital in Harper, Maryland County. According Arnold currently no microbiology testing is carried out in the South-east region of Liberia: AMR is actually considered a bigger threat in low-resource settings since there is no evidence guided treatment. Arnold is tasked with Training lab personnel on microbiological test procedures with a major bias to bacterial infections. He is also helping to get the lab to SLIPTA accreditation for Quality Management System. Earlier he was involved in publications regarding CNS infections,  MRSA nasal carriage & TB diagnosis & treatment studies.

Peter Babigumira Ahabwe works as a Senior Program Pharmacist at the Infectious Diseases Institute (IDI), Makerere University in Uganda. He serves as an interface between the IDI and the Ministry of Health on projects where science and policy overlap. He contributes to achieving Global Health Security Agenda targets in Uganda. Peter represents IDI on the National AMR Technical working committee for Antimicrobial Stewardship and Optimal Use, Logistics and Coordination Subcommittees of the National Task force, AMR Conference Planning and Scientific committees and Appropriate Medicines Use Advisory Group. He has supported the development of National Guidelines for Antibiotic stewardship. Peter also coordinates the GPPS data submission in Uganda and gives strategic oversights to the Antimicrobial Resistance (AMR) eLearning and call center at IDI. Peter intends to  revitalize Medicine and Therapeutics committees of hospitals as an entry point for Antibiotic Stewardship interventions. Also he hopes to measure the burden of inappropriate antibiotic use in public health emergencies and disasters.

Denise Delaney is a Senior Director working at Sustainability in London, UK. She leads strategy and stakeholder engagement projects and is an expert in the pharma and healthcare arena. Denise has international experience working with both national and global development organizations and NGOs (including UN’s ECLAC and UNHCR), mainly in Latin America and India. Denise has led SustainAbility’s work on the topic of AMR. The company became involved in the topic in 2017 after the landmark year of emphasis on AMR (2016). SustainAbility worked closely with the AMR Industry Alliance to develop a measurement framework and deliver the very first report on the progress made against its commitments. Denise believes that industry has a clear role to play in tackling AMR – from the science and innovation, to ensuring access while also promoting stewardship, to limiting the environmental impact of manufacturing. She regularly raises the alarm and builds awareness in her work on AMR.

Tholwana Pelokgosi works as a Medical Laboratory Scientist at the Ministry of Health in Botswana. Tholwana currently works in the Microbiology Laboratory. This lab receives patient samples and processes these by culturing in order to do biochemical and antimicrobial susceptibility tests. Then they release results to the clinicians who will then assist patients based on the outcome of the results. Her current contribution to curbing AMR is emphasizing that the updated Clinical and Laboratory Standard Institute guidelines are followed strictly when setting up antibiotics in a patient sample. She intends to be part of the antimicrobial stewardship committee in Botswana. Tholwana also intends to mentor young  medical laboratory professionals and students on proper use of antibiotics and enlighten the about antimicrobial resistance. Tholwana was part of the team that was validating Botswana’s action plan on AMR. She intends to apply for Masters in AMR to become part of the policy makers in Botswana.

Luciana Sartori is a Clinical Microbiologist and Infectologist as well as a General Coordinator at Animal Care Ipiranga Veterinary Hospital, Ipiranga in Brasil. Her intended contribution to curbing AMR is to exchange ideas and protocols on nosocomial infections in veterinary medicine. She will also contribute by sharing her knowledge of AMR in production and companion animals.

Yinka Odebode is a Lecturer/ Research Scientist at Kabale University in Uganda. He teaches, supervises and does community service as a responsible citizen. His intended contribution to curbing AMR is to highlight the need for an improved understanding of the mechanisms and processes that underlie emergence and spread of resistance, create awareness about infections, and give attention to methods that can be used to prevent and control them. Yinka is also doing research work on environmental reservoirs of AMR in Uganda. He will continue to collaborate to detect and monitor resistance for the effective management of fungal diseases towards sustainable food production systems and resilient agricultural practices.

Raymond Okechukwu is Assistant Director of Pharmaceutical Services in the Centre for Community Medicine and Primary Healthcare, of the Nnamdi Azikiwe University Teaching Hospital, Nnewi, Nigeria. He provides pharmaceutical care and hospital pharmacy services to ambulatory, intensive care and hospitalized patients. He is a member of the ‘Global Advocates for Quality and Safety in Healthcare’ and Assistant Chair of the Quality Improvement Committee of the teaching hospital. Also he is the responsible officer for Inventory and Logistics Management Information System (LMIS) for the National HIV / AIDS Care, Malaria and TB Control Program in the Centre. As the lead researcher in the hospital-wide antimicrobial stewardship programme he concluded the baseline survey of the “Perceptions, Attitudes And Practices Of Antimicrobial Stewardship Among Health Workers In A Nigerian University Teaching Hospital.”

Mohammed Zabiuddin Ahad has completed his PharmD degree from Manipal Academy of Higher Education, Manipal, India. Since then he is working with a research team with primary focus on Antimicrobial Stewardship. He is currently engaged in a project funded by Indian Council of Medical Research (ICMR) titled “Initiating Antimicrobial Stewardship Activities in Hospitals in India”, a program run at Kasturba Hospital, Manipal, a 2000 bedded tertiary care teaching hospital in the southern part of India. As part of WAAW and other educational events, he has coordinated multiple teams of volunteers and created awareness among community pharmacists on AMR.

Eriola-Sophia Shanko is the founder and CEO of ShanX Medtech in The Netherlands. The company’s vision is to create a more sustainable and safe future by raising awareness and delivering high-end diagnostic platforms to combat AMR. She sees many frontiers to tackle AMR: raising awareness, developing diagnostic tools and new drug formulations or implementing new policies. In her company she focuses on developing rapid and high precision diagnostic platforms for drug testing. This way they hope to assist the doctor to the appropriate drug prescription based on scientific data and not empirical use. Eriola is highly motivated to add to raising global awareness on AMR by becoming an AMR ambassador.

Wame Kgwakgwe, works for Water Utilities Corporation (WUC) which is an organization that provides drinking water and waste water services throughout Botswana. Wame is responsible for  Laboratory quality management system implementation, test facilities, effluent analyses  through quality control tests, internal auditing and much more. Wame is committed to collaborate with NGOs to raise awareness on AMR, conduct presentations at her workplace on AMR, encourage AMR related research and promote awareness by holding workshops/conferences to present AMR related research findings. Last but not least she will share AMR related information with other AMR ambassadors and work closely with WHO on different initiatives to curb AMR.

Shamshul Ansari, currently Assistant Professor in Microbiology and Immunology at Chitwan Medical College, Bharatpur, Nepal. Shamshul obtained his PhD at Oita University Faculty of Medicine, Oita, Japan and has been teaching microbiology and infectious diseases. In research he has a keen interest in AMR and has published several papers in high impact journals. Although a challenging problem across the world AMR is more problematic in developing countries like Nepal. The lack of national guidelines regarding prescription of antibiotics and the lack of sufficient knowledge about consequences of the (mis)use of antibiotics on community level contribute to resistance development. Expert professionals need to work on these issues to combat the antimicrobial resistance development. “Use antibiotics judicially to combat the development of resistance”.

Amine Zorgani, R&D Microbiology Manager and team leader at Nuritas in Ireland. He leads a team of experienced Microbiologists to uncover the potential bioactivities of plant-derived peptides. Ireland-based Nuritas uses artificial intelligence to predict bioactive peptides from plant genomes to target several (ESKAPE) human pathogens and food spoiling microbes.The mission of Nuritas is to find new antimicrobial therapies from a natural origin. Amine started his fight against AMR during his Ph.D. study. When he started working with Nuritas in 2017 he realised that his journey with AMR had just started…

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!